Paid Study | Hep C Online Communities

The Henne Group is conducting regarding Hepatitis C research by creating an online community which will be exploring the experiences of people living with Hep C.

+

Diagnosing & Managing Hep C: City Health Information (NYC Health Dept)

The NYC Health Department recently released the 2018 version of City Health Information (CHI): Diagnosing & Managing Hep C providing guidance to Primary Care Providers in hepatitis C screening, management and treatment.

+

Call for Abstracts | NYC Viral Hepatitis Research Symposium (Due 3/29/18)

Now is the time to submit your abstract to become part of the 2018 NYC Viral Hepatitis Research Symposium! The primary focus of the meeting is on addressing viral hepatitis in special populations. Authors are encouraged to submit abstracts on their research and health care evalua...

+

Olysio-Sovaldi Combo Becomes 2nd FDA-approved All-oral HCV Treatment

Olysio has been approved by the FDA, in combination with Sovaldi, for the treatment of Hepatitis C. It is substantially more expensive than Harvoni; although it depends on treatment time, a 12-week Harvoni treatment costs $94,500, compared to the Olysio-Sovaldi 12-week tag of $1...

+

New Two-Dose Hep B Vaccine Recommended by the Advisory Committee on Immunization Practices

The Advisory Committee on Immunization Practices’ (ACIP) recommend HEPLISAV-B™ for use among individuals age 18 years and older to prevent hepatitis B infection (HBV).